ABSI Absci Corporation

NASDAQ
$7.58

Absci Corporation (ABSI) is expected to report earnings on February 11, 2027, before the market open. The consensus earnings estimate is a loss of $0.18 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -19.3% since its last earnings release on November 12, 2026.

Absci Reported In-line with Expectations
Thursday, November 12, 2026 · 7:05 AM ET
Earnings Date
4th Quarter, Dec 2026
Feb 11
Thursday · 7:30 AM ET
Earnings Whisper
-
vs ($0.18)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $8.21

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Absci Corporation

Absci is the drug and target discovery company harnessing deep learning AI and synthetic biology to expand the therapeutic potential of proteins.

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.